Shares of Viking Therapeutics (VKTX) rose 7.3% to $6.03 at 15:16 EST on Friday, following the last session’s upward trend. NASDAQ Composite (VKTX) is jumping 0.13% to $14,038.22, following the last session’s upward trend. This seems, at the moment, a somewhat bullish trend exchanging session today.
Viking Therapeutics’s last close was $5.62, 44.3% under its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 1753716 which is 86.64% above its average volume of 939642.
The company’s growth estimates for the ongoing quarter and the next is a negative 53.8% and a negative 61.5%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 2.07%, a negative 0.43%, and a positive 2.42%, respectively.
Viking Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.19% (last week), 2.18% (last month), and 2.42% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be oversold (<=20).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $6.03 at 15:16 EST, way under its 52-week high of $10.09 and way higher than its 52-week low of $4.95.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s value is above its 50-day moving average of $5.81 and below its 200-day moving average of $6.46.
More news about Viking Therapeutics (VKTX).